Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySamsrita Labs Ltd 2CIN NO.L85110TG1996PLC099198 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: NA Designation: NA EmailId: pcproductsindia@gmail.com Name of the Chief Financial Officer: K N V Narendra Kumar Designation: Director and CFO EmailId: pcproductsindia@gmail.com Date: 30/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Samsrita Labs Ltd.

28 Apr 2025

24.11

4.96%

Company Update

Samsrita Labs Ltd - 539267 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Publication of Audited financials of the company for the year ended 31-03-2025

pdf

Samsrita Labs Ltd.

26 Apr 2025

24.11

4.96%

Board Meeting

Samsrita Labs Ltd - 539267 - Board Meeting Intimation for Increase In Authorized Capital Of The …

BSE India

Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 ,inter alia, to consider and approve Increase in Authorized Capital of the company and Raising of funds through issue of equity shares, convertible warrants or any such other securities on preferential basis

pdf

Samsrita Labs Ltd.

26 Apr 2025

24.11

4.96%

Result

Samsrita Labs Ltd - 539267 - AUIDTED FINANCIAL RESULTS OF THE COMPANY FOR THE YEAR ENDED …

BSE India

AUDITED FINANCIAL RESULTS OF THE COMPANY FOR THE YEAR ENDED 31-03-2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.00	0.00	0.00	-	-
Operating Profit Qtr	-0.09	-0.04	-0.07	-125.0%	-28.6%
Net Profit Qtr	-0.09	-0.04	-0.07	-125.0%	-28.6%
Earning Per Share Adjusted latest Qtr	-0.06	-0.03	-0.05	-100.0%	-20.0%

* Standalone data

Detailed Results

Samsrita Labs Ltd.

26 Apr 2025

24.11

4.96%

Company Update

Samsrita Labs Ltd - 539267 - INTIMATION FOR APPOINTMENT OF INTERNAL AUDITOR AND SECRETARIAL AUDITOR OF …

BSE India

INTIMATION FOR APPOINTMENT OF INTERNAL AUDITOR AND SECRETARIAL AUDITOR OF THE COMPANY

pdf

Samsrita Labs Ltd.

26 Apr 2025

24.11

4.96%

Board Meeting

Samsrita Labs Ltd - 539267 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board meeting held on 26-04-2025 for approval of audited financials of the company for the quarter and year ended on 31-03-2025 and appointment of Internal Auditors and Secretarial Auditors of the company

pdf

Is Dr. Habeebullah Life Sciences Ltd. worth buying?

5 Votes:

Buy 80.0%

Hold 20.0%

25.49% Fall from 52W High

High volume today

Samsrita Labs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Samsrita Labs Ltd. on BSE